Biomarkers play a pivotal role in modern life science research, from identifying disease signatures to guiding therapeutic development and monitoring treatment response. In this multi-perspective webinar, hear from experts applying unique strategies, tools, and analytical techniques to move biomarker discovery and application forward.
Sarah Kotanchiyev, MLS (ASCP)CMField Application Scientist, Slingshot Biosciences
Sarah Kotanchiyev, MLS (ASCP)CM will discuss how Slingshot Biosciences' precision-engineered cell mimics are advancing biomarker-driven research. These innovative controls provide a more reliable, reproducible, and scalable alternative to biological controls, reducing variability in biomarker assays and improving standardization across flow cytometry and other cell-based applications.
Sunghyun Huh, PhDHead of Bioinformatics, Bertis Inc.
During the webinar, Sunghyun Huh,PhD will present key insights into three critical areas. First, he will demonstrate omics analysis, with a particular focus on the proteomic approach for uncovering biological phenomena. Second, he will highlight strategies for identifying disease-specific biomarkers, which have the potential to serve as both diagnostic and therapeutic signatures. Lastly, the presentation will delve into deciphering the molecular mechanisms underlying these biomarkers, providing a clearer understanding of their efficacy and applicability in clinical settings. Each topic will be presented with study cases conducted at Bertis.
Julie Ann Mayer, PhDVice President, Global Biomarker Platform, Crown Bioscience
Join Julie to delve into the evolving landscape of clinical biomarker services and translational oncology solutions. She will explore how an integrated approach - combining access to clinically relevant tumor materials with advanced biomarker analysis - unlocks deeper insights into cancer biology and therapeutic response. Discover real-world applications and case studies that demonstrate how Crown's end-to-end services are accelerating oncology drug development, from early discovery through clinical translation.
Presenters
Sarah Kotanchiyev
Sarah Kotanchiyev, MLS (ASCP)CM has a background of over 8 years of experience in clinical flow cytometry at Emory University Hospital where she was heavily involved in new assay development, validation, and implementation. She was the initial field applications scientist at Slingshot and has grown the position over the past two and a half years to better serve our customers. In her role she plays a key role in assisting customers with implementing our catalog and custom products into their workflow for more streamlined efficiency.
Sunghyun Huh
Dr. Sunghyun Huh is the Head of the Biomedical Informatics team at Bertis Inc., specializing in biomarker discovery and systems biology analysis to support the company's diagnostic assay development and analytic service. With a strong background in bioinformatics using mass spectrometry-based proteomics data, he holds a Ph.D. in systems biology from DGIST (Daegu Gyeongbuk Institute of Science and Technology). Prior to joining Bertis, Sunghyun worked as a post-doctoral researcher at Seoul National University and as a student researcher at IBS (Institute for Basic Science), gaining extensive experience in multi-omics data analysis spanning various biological systems and topics.
Julie Ann Mayer
Dr. Julie Ann Mayer has held progressive scientific and leadership roles spanning R&D and Operations at several molecular diagnostics companies, including NeoGenomics Laboratories, Biocept Inc., and Navigate BioPharma Services (a Novartis subsidiary). She has extensive precision medicine experience, having developed, validated, and launched >50 diagnostic assays for production and clinical trial testing in multiple CLIA/CAP accredited laboratories. Before joining industry, Dr. Mayer received her post-doctoral training in translational breast cancer research at Baylor College of Medicine and in clinical cancer prevention at MD Anderson Cancer Center and obtained her Ph.D in Pathology from the University of Southern California.
Sponsor
Crown Bioscience
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
